Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate
- Development stage
- Unknown
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
This compound is a synthetic nucleotide analogue structurally related to xanthines and purine derivatives. It features a modified purine base (xanthine core), a tetrahydroxypentyl side chain (mimicking ribose), and a propyl dihydrogen phosphate group. Nucleotide analogues like this are often used as biochemical probes or in research settings to study enzyme interactions with nucleotides or as potential antiviral agents by mimicking natural nucleotides and interfering with viral replication processes. There is no evidence of clinical use or approval for therapeutic indications[1][9].
- Other names
- (3-(2,6,8-trioxo-9-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)-1H-purin-7-yl)propoxy)phosphonic acid(3-{2,6,8-trioxo-9-[(2S,-3S,-4R)-2,-3,-4,-5-tetrahydroxypentyl]-1H-purin-7-y}propoxy)phosphonic acid
Beyond the preview
Go deeper on 3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate.